Design Therapeutics Inc

NASDAQ DSGN

Data sourced from iex and EODHD
Download Data

Design Therapeutics Inc Cash Flow Statement 2019 - 2023

This table shows the Cash Flow Statement for Design Therapeutics Inc going from 2019 until 2023. The cash flow statement is a financial statement that shows the inflow and outflow of cash and cash equivalents from a company's operating, investing, and financing activities over a specified period. It provides crucial information about a company's ability to generate and manage cash, which is essential for its day-to-day operations, investments, and debt obligations.
Cash Flow Statement Trend Unit 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Net Income
M -67 -63 -36 -8 -2
Depreciation and Amortization
M 1 0 0 0 0
Non-Cash Items (Other)
M 9 -1 0 0 0
Operating Cash Flow
M -59 -51 -29 -9 0
Capital Expenditures
M 0 -1 -2 0 0
Net Acquisitions
M - - - - -
Other Investing Activities
M - 0 - - -
Investing Cash Flow
M - 0 - - -
Repayment/Issuance of Debt (Net)
M - 0 - 0 0
Equity Repurchase (Common, Net)
M 0 0 0 - -
Dividends Paid
M - - - - -
Other Financial Activities
M 0 0 0 45 0
Financing Cash Flow
M 0 0 0 45 0
Exchange Rate Adjustment
M - - - - -
Beginning Cash
M 27 299 2 0 0
Ending Cash
M 21 27 299 2 0
Stock-Based Compensation
M 13 11 5 0 0
Issuance/Purchase of Shares
M 0 0 0 - -
Capital Stock Change
M - 0 379 45 0
Working Capital
M 275 324 380 34 -4
Free Cash Flow
M -59 -52 -31 -9 0

StockViz Staff

September 19, 2024

Any question? Send us an email